
Eneda Toska, PhD
Principal Investigator
Email: etoska1@jhmi.edu
- University at Buffalo – PhD
- Memorial Sloan Kettering Cancer Center – Postdoctoral Fellowship
- Memorial Sloan Kettering Cancer Center – Senior Research Scientist
Grants
- K22 NCI Transition to Independence Award
- Innovation in Cancer Informatics
- Breast Cancer Research Alliance
- Jayne Koskinas Ted Giovanis Foundation for Health and Policy
- National Cancer Institute 1R21CA252530-01A1
- National Cancer Institute R01 R01CA276187
- American Cancer Society Research Scholar Award
Eneda Toska, Ph.D., is an Associate Professor of Oncology at the Johns Hopkins Kimmel Cancer Center and a member of the Cancer Invasion and Metastasis Program (CIM), working in close collaboration with the Breast and OBGYN Group. Dr. Toska also holds a secondary faculty appointment in the Department of Biochemistry and Molecular Biology (BMB) at the Johns Hopkins Bloomberg School of Public Health and is a member of the BMB Ph.D. program. She is also affiliated with the Department of Pathobiology at the Johns Hopkins University School of Medicine, the Convergence Institute, and the Epigenome Sciences Cluster.
Dr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester. She received her master’s degree and doctorate from the University at Buffalo and subsequently completed her postdoctoral training with the late Dr. José Baselga at Memorial Sloan Kettering Cancer Center (MSKCC), where she later served as a Senior Research Scientist.
Dr. Toska has received numerous awards and honors, including the 2025 American Cancer Society Research Scholar Award, the 2023 AACR Cancer Research Early Career Award, and selection as a 2021 AACR NextGen Star. Her other honors and research support include the Breast Cancer Research Alliance Young Investigator Award, an NCI K22 Transition Career Development Award, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, and support from the Innovation in Cancer Informatics program.
Dr. Toska is a permanent member of the National Institutes of Health (NIH) Biochemistry and Cellular Oncogenesis (BCO) Study Section (2025–2029). She has also served in leadership and review roles for major cancer research meetings, including chairing the Epigenetics program at AACR and serving as an abstract reviewer for both AACR and the San Antonio Breast Cancer Symposium (SABCS). She also organizes multiple scientific seminar series.
Her research program focuses on the intersection of epigenetic regulation and oncogenic cell signaling, with an emphasis on understanding how chromatin and transcriptional programs contribute to cancer progression and therapeutic resistance. Her translational research focuses particularly on mechanisms of endocrine therapy resistance in breast cancer.